Active Ingredient History
Diphtheria vaccine is a toxoid vaccine against diphtheria, an illness caused by Corynebacterium diphtheriae. Its use has resulted in a more than 90% decrease in number of cases globally between 1980 and 2000. The first dose is recommended at six weeks of age with two additional doses four weeks apart, after which it is about 95% effective during childhood. Three further doses are recommended during childhood. It is unclear if further doses later in life are needed. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Diphtheria (approved 1926)
Clostridium Infections (Phase 2)
Diphtheria (Phase 4)
Diphtheria-Tetanus-Pertussis Vaccine (Phase 3)
Diphtheria Toxoid (Phase 2)
Glioblastoma (Phase 2)
Glioma (Phase 2)
Haemophilus Infections (Phase 3)
Haemophilus influenzae type b (Phase 3)
Hepatitis B (Phase 3)
HIV Infections (Phase 1)
Influenza, Human (Phase 3)
Kidney Transplantation (Phase 4)
Lung Neoplasms (Phase 1/Phase 2)
Malaria (Phase 3)
Meningitis, Meningococcal (Phase 4)
Meningococcal Infections (Phase 4)
Multiple Sclerosis (Phase 4)
Pertussis Vaccine (Phase 4)
Pneumococcal Infections (Phase 4)
Poliomyelitis (Phase 3)
Rotavirus Infections (Phase 3)
Tetanus (Phase 4)
Typhoid Fever (Phase 1/Phase 2)
Vaccines (Phase 4)
Whooping Cough (Phase 3)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
